RNF113A
Basic information
Region (hg38): X:119870475-119871733
Previous symbols: [ "ZNF183" ]
Links
Phenotypes
GenCC
Source:
- trichothiodystrophy 5, nonphotosensitive (Limited), mode of inheritance: XL
- trichothiodystrophy (Supportive), mode of inheritance: AR
- trichothiodystrophy 5, nonphotosensitive (Limited), mode of inheritance: XL
- trichothiodystrophy 5, nonphotosensitive (Moderate), mode of inheritance: XL
- trichothiodystrophy 5, nonphotosensitive (Strong), mode of inheritance: XL
- trichothiodystrophy 5, nonphotosensitive (Limited), mode of inheritance: XL
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Trichothiodystrophy 5, nonphotosensitive | XL | Allergy/Immunology/Infectious | The condition can involve recurrent infections, and awareness may allow preventive measures, and early and aggressive treatment of infections | Allergy/Immunology/Infectious; Craniofacial; Dermatologic; Endocrine; Genitourinary; Musculoskeletal; Neurologic | 19377476; 25612912; 31130284; 31880405 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (95 variants)
- not_specified (21 variants)
- Trichothiodystrophy_5,_nonphotosensitive (10 variants)
- RNF113A-related_disorder (6 variants)
- Abnormal_cerebral_morphology (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF113A gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006978.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 13 | 17 | 31 | |||
| missense | 68 | 76 | ||||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 4 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 5 | 82 | 22 | 2 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| RNF113A | protein_coding | protein_coding | ENST00000371442 | 1 | 1295 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.889 | 0.110 | 0 | 0 | 0 | 0 | 0.00 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.77 | 77 | 135 | 0.571 | 0.00000897 | 2285 |
| Missense in Polyphen | 5 | 37.296 | 0.13406 | 631 | ||
| Synonymous | 0.721 | 45 | 51.6 | 0.872 | 0.00000350 | 646 |
| Loss of Function | 2.47 | 0 | 7.13 | 0.00 | 4.58e-7 | 132 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.00 | 0.00 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that catalyzes the transfer of ubiquitin onto target proteins (PubMed:28978524, PubMed:29144457). Catalyzes polyubiquitination of SNRNP200/BRR2 with non-canonical 'Lys-63'-linked polyubiquitin chains (PubMed:29144457). Plays a role in DNA repair via its role in the synthesis of 'Lys-63'-linked polyubiquitin chains that recruit ALKBH3 and the ASCC complex to sites of DNA damage by alkylating agents (PubMed:29144457). Ubiquitinates CXCR4, leading to its degradation, and thereby contributes to the termination of CXCR4 signaling (PubMed:28978524). {ECO:0000269|PubMed:28978524, ECO:0000269|PubMed:29144457}.;
Recessive Scores
- pRec
- 0.0928
Intolerance Scores
- loftool
- rvis_EVS
- 0.55
- rvis_percentile_EVS
- 81.22
Haploinsufficiency Scores
- pHI
- 0.155
- hipred
- Y
- hipred_score
- 0.592
- ghis
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnf113a1
- Phenotype
Zebrafish Information Network
- Gene name
- rnf113a
- Affected structure
- anatomical system
- Phenotype tag
- abnormal
- Phenotype quality
- quality
Gene ontology
- Biological process
- DNA repair;mRNA processing;protein ubiquitination;isopeptide cross-linking via N6-glycyl-L-lysine;snoRNA splicing;negative regulation of chemokine-mediated signaling pathway
- Cellular component
- U2-type spliceosomal complex;nuclear speck
- Molecular function
- ubiquitin-protein transferase activity;protein binding;metal ion binding